Key result
Higher mean heart rate is linked to ~10% higher odds of severe fatigue in HCC.
Why the study?
The potential association between fatigue, sleep disturbances, and autonomic nervous system function reflected by heart rate variability in HCC patients was unclear.
Cross-Sectional (n=66)
No
Odds Ratio: 1.098 (95% CI 1.031–1.17)
p-value: p=0.004
Alterations in heart rate variability, specifically increased mean heart rate, are significantly correlated with the severity of fatigue in patients undergoing interventional therapy for hepatocellular carcinoma, suggesting it may serve as an objective physiological marker of symptom burden.
Higher mean heart rate may flag severe fatigue risk in HCC interventional patients; cross-sectional data leave causal and clinical utility open.
Background Fatigue and sleep disturbances are commonly experienced by patients with hepatocellular carcinoma (HCC). However, the potential association between these conditions and autonomic nervous system reflected by heart rate variability (HRV) is unclear. We aimed to evaluate the differences in HRV parameters among HCC patients with different degrees of fatigue and sleep disturbances, as well as the relationship between HRV parameters and fatigue and sleep disturbances. Methods In this cross-sectional study, a total of 66 patients with HCC hospitalized for interventional therapy were enrolled. Patients completed questionnaires during hospitalization, including the Pittsburgh Sleep Quality Index (PSQI) and the Fatigue Scale-14 (FS-14), and underwent a 5-minute resting electrocardiogram (ECG) for HRV analysis. Group comparisons and logistic regression models adjusted for age were used to examine the associations between HRV parameters and symptom severity, with Benjamini-Hochberg false discovery rate (FDR) correction for multiple comparisons. Results Acceleration capacity (AC) was significantly higher and low frequency (LF) was significantly lower in the high PSQI group compared to the low PSQI group (AC: p = 0.036; LF: p = 0.041); Compared to the low FS-14 group, the high FS-14 group had significantly higher mean heart rate (MeanHR) and AC, while most other HRV indices were significantly lower (MeanHR: p = 0.029; AC: p = 0.009). The results of the adjusted logistic regression model indicated that increased AC showed a marginal trend toward an association with poor sleep quality (p = 0.071), while MeanHR remained significantly associated with severe fatigue (OR = 1.098, p = 0.004). After FDR correction, the differences in eight HRV parameters between fatigue groups remained significant (all q < 0.05), whereas the differences between sleep-quality groups did not survive correction. Conclusions Our findings suggest that alterations in HRV parameters, particularly mean heart rate (MeanHR) and acceleration capacity (AC), are associated with the severity of fatigue and sleep disturbances in HCC patients. Given the exploratory cross-sectional design, these metrics should be regarded as candidate non-invasive physiological correlates of autonomic dysfunction and symptom burden. Their clinical relevance requires confirmation in larger prospective studies.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) conducted a cross-sectional in Hepatocellular Carcinoma (n=66). Mean heart rate (MeanHR) was evaluated on Severe fatigue (FS-14 score ≥6) (OR 1.098, 95% CI 1.031-1.170, p=0.004). Higher mean heart rate was independently associated with an increased odds of severe fatigue in patients with hepatocellular carcinoma undergoing interventional therapy (OR 1.098).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: